JCIA
CSTL icon

Jackson Creek Investment Advisors’s Castle Biosciences CSTL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,214
Closed -$275K – 342
2026
Q1 		$275K Sell
11,214
-21
-0.2% -$688 0.08% 288
2025
Q4 		$437K Buy
+11,235
New +$362K 0.13% 227
2025
Q2 		– Sell
-57,094
Closed -$1.14M – 328
2025
Q1 		$1.14M Buy
+57,094
New +$1.41M 0.36% 153

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's CSTL Position: Q2 2026 in Review

Jackson Creek Investment Advisors sold out of Castle Biosciences (CSTL) in Q2 2026, closing a stake of 11,214 shares — an estimated $275K sold.

Jackson Creek Investment Advisors first reported a position in CSTL in Q1 2025 and held it in 3 quarters. The position peaked at $1.14M in Q1 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Jackson Creek Investment Advisors reported no remaining Castle Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 11,214 Castle Biosciences shares in Q2 2026, an estimated $275K.
  • Jackson Creek Investment Advisors first reported a position in Castle Biosciences in Q1 2025 and held it in 3 quarters.
  • Jackson Creek Investment Advisors's Castle Biosciences position peaked at $1.14M in Q1 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.